It has also been reported that high ASF1B expression is closely related to poor outcomes of patients with renal cell cancer, cervical cancer, and breast cancer (Corpet et al., 2011; Han et al., 2018; Jiangqiao et al., 2019; Liu et al., 2020). Here, ASF1B is linked to breast carcinoma.